- Home
- WFC vs NVS Comparison
WFC vs NVS Comparison
Compare WFC & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFC
- NVS
- Stock Information
- Founded
- WFC 1852
- NVS 1895
- Country
- WFC United States
- NVS Switzerland
- Employees
- WFC N/A
- NVS N/A
- Industry
- WFC Major Banks
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- WFC Finance
- NVS Health Care
- Exchange
- WFC Nasdaq
- NVS Nasdaq
- Market Cap
- WFC 235.8B
- NVS 230.5B
- IPO Year
- WFC N/A
- NVS 1991
- Fundamental
- Price
- WFC $70.36
- NVS $97.08
- Analyst Decision
- WFC Buy
- NVS Hold
- Analyst Count
- WFC 22
- NVS 6
- Target Price
- WFC $67.82
- NVS $121.25
- AVG Volume (30 Days)
- WFC 18.5M
- NVS 1.1M
- Earning Date
- WFC 01-15-2025
- NVS 01-31-2025
- Dividend Yield
- WFC 2.27%
- NVS 3.89%
- EPS Growth
- WFC 1.87
- NVS 130.53
- EPS
- WFC 4.79
- NVS 8.58
- Revenue
- WFC $77,875,000,000.00
- NVS $49,940,000,000.00
- Revenue This Year
- WFC N/A
- NVS $10.04
- Revenue Next Year
- WFC $0.50
- NVS $4.55
- P/E Ratio
- WFC $14.69
- NVS $11.02
- Revenue Growth
- WFC 1.03
- NVS 8.92
- 52 Week Low
- WFC $46.12
- NVS $92.35
- 52 Week High
- WFC $78.13
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- WFC 46.28
- NVS 27.93
- Support Level
- WFC $68.61
- NVS $97.69
- Resistance Level
- WFC $72.29
- NVS $99.67
- Average True Range (ATR)
- WFC 1.73
- NVS 1.01
- MACD
- WFC -0.79
- NVS -0.18
- Stochastic Oscillator
- WFC 24.10
- NVS 10.97
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.